Clinical Trial Update: Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events [Phase 4]

View source ↗

Summary

Phase 4 trial assessing folic acid to prevent cardiovascular events in patients with uremia and hyperhomocysteinemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• Hyperhomocysteinemia
• Uremia

Drugs mentioned

• folic acid (folic acid)

Snippet

Sponsor: Universidade Estadual de Londrina | Conditions: Uremia, Chronic Renal Failure | Phase 4 | Status: COMPLETED